Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Im­muno­log­i­cal Medicines for Cat­tles

Immunological veterinary medicinal products, including vaccines, are authorised for cattle.

Search results 1 to 25 from a total of 64

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Aftop­ur Al­Sap

Maul- und Klauenseuche

Boehringer In­gel­heim Vetmed­i­ca GmbH

BFAV-B 366 17.12.2003 Rind, Schaf, Ziege

Aftop­ur DOE

Maul- und Klauenseuche

Boehringer In­gel­heim Vetmed­i­ca GmbH

BFAV-B 367 17.12.2003 Rind, Schaf, Ziege, Schwein

Afto­vax­pur DOE

Maul- und Klauenseuche

Boehringer In­gel­heim Vetmed­i­ca GmbH

EU/2/13/153/001-850 15.07.2013 Rind, Schaf, Schwein

EPAR: Afto­vax­pur DOE

Anis­erin or­in­ject

Serum gegen Ro­tavirus-In­fek­tion,
Coro­n­avirus-In­fek­tion,
E. coli-In­fek­tion

ani­Med­i­ca GmbH

107a/91 22.09.1994 Rind

Bio­fakt Al­brecht

Serum gegen Ro­tavirus-In­fek­tion,
Coro­n­avirus-In­fek­tion,
E. coli-In­fek­tion

Dechra Vet­eri­nary Prod­ucts Deutsch­land GmbH

PEI.V.03587.01.1 14.06.2008 Rind

Blue­vac BTV

Blauzun­genkrankheit, Serotyp 8, 4 oder 1

CZ Vet­eri­nar­ia S.A., Spanien

EU/2/11/122/001-003 14.04.2011 Schaf, Rind

EPAR: Blue­vac BTV

Blue­vac-4

Blauzun­genkrankheit, Serotyp 4

CZ Vet­eri­nar­ia S.A., Spanien

PEI.V.11839.01.1 25.05.2016 Schaf, Rind

BO­VAL­TO Respi 3

En­zoo­tis­che Bron­chop­neu­monie,
BRSV-In­fek­tion, Parain­fluen­za-3, Pas­teurel­lose

Boehringer In­gel­heim Vetmed­i­ca GmbH

PEI.V.11801.01.1 01.12.2015 Rind

BO­VAL­TO Respi 4

En­zoo­tis­che Bron­chop­neu­monie,
BRSV-In­fek­tion, Parain­fluen­za-3, BVD/MD, Pas­teurel­lose

Boehringer In­gel­heim Vetmed­i­ca GmbH

PEI.V.11802.01.1 01.12.2015 Rind

BO­VAL­TO Respi In­tranasal

BRSV-In­fek­tion, Parain­fluen­za-3

Boehringer In­gel­heim Vetmed­i­ca GmbH

PEI.V.11947.01.1 19.03.2018 Rind

Bovela

BVD/MD

Boehringer In­gel­heim Vetmed­i­ca GmbH

EU/2/14/176/001-016 22.12.2014 Rind

EPAR: Bovela

BOVI­GEN SCOUR

Ro­tavirus-In­fek­tion, Coro­n­avirus-In­fek­tion,
E. coli-In­fek­tion

FORTE Health­care Ltd., Ir­land

PEI.V.11715.01.1 24.02.2015 Rind

Bovi­grip RSP plus

En­zoo­tis­che Bron­chop­neu­monie, BRSV-In­fek­tion, Parain­fluen­za-3, Pas­teurel­lose

In­ter­vet Deutsch­land GmbH

PEI.V.02900.01.1 20.07.2004 Rind

Bovilis Blue-8

Blauzun­genkrankheit, Serotyp 8

In­ter­vet In­ter­na­tion­al B.V., Nieder­lande

EU/2/17/218/001-003 21.11.2017 Rind, Schaf

EPAR: Bovilis Blue-8

Bovilis BVD-MD

BVD/MD

In­ter­vet Deutsch­land GmbH

180a/96 18.05.1998 Rind

Bovilis Cryp­tium

Kryp­tosporid­iose

In­ter­vet In­ter­na­tion­al B.V., Nether­lands

EU/2/23/303 24.11.2023 Rind

EPAR: Bovilis Cryp­tium

Bovilis IBR Mark­er in­ac

BHV1-In­fek­tion

In­ter­vet Deutsch­land GmbH

PEI.V.03246.01.1 23.09.2005 Rind

Bovilis IBR Mark­er live

BHV1-In­fek­tion

In­ter­vet Deutsch­land GmbH

PEI.V.11616.01.1 02.02.2012 Rind

Bovilis In­traNasal RSP Live

BRSV-In­fek­tion, Bovine Parain­fluen­za

In­ter­vet Deutsch­land GmbH

PEI.V.11976.01.1 18.05.2019 Rind

Bovilis Nasal­gen-C

Coro­n­avirus-In­fek­tion

In­ter­vet In­ter­na­tion­al B.V., Nether­lands

EU/2/23/294 31.03.2023 Rind

EPAR: Bovilis Nasal­gen-C

Bovilis Ring­vac

Tri­chophytie

In­ter­vet Deutsch­land GmbH

PEI.V.00287.01.1 29.03.2001 Rind

Bovilis Ro­tavec Coro­na

Ro­tavirus-In­fek­tion, Coro­n­avirus-In­fek­tion, E.coli-In­fek­tion

In­ter­vet Deutsch­land GmbH

PEI.V.01312.01.1 13.04.2000 Rind

Bovit­ri­chon

Tri­chophytie

Ecuphar NV, Bel­gien

PEI.V.01863.02.1 10.12.2014 Rind

Bravox­in

En­tero­toxämie, Rauschbrand, Para­rauschbrand, Deutsche Brad­sot, Gasö­dem, Tetanus, In­fek­tiöse Hä­moglobin­urie

In­ter­vet Deutsch­land GmbH

PEI.V.12037.01.1 03.08.2020 Rind, Schaf

Bravox­in 10

En­tero­toxämie, Rauschbrand, Para­rauschbrand, Deutsche Brad­sot, Gasö­dem, Tetanus, In­fek­tiöse Hä­moglobin­urie

In­ter­vet Deutsch­land GmbH

PEI.V.03633.01.1 21.10.2008 Rind, Schaf

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 514 in BAnz AT 01.03.2024 B8.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 04.03.2024